Breast and ovarian cancer UPDATE: July 20-28, 2016 :: Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)



July 20-28, 2016 


Last Updated: Jul 20, 2016

• Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
  Modell Stephen M et al. Healthcare (Basel, Switzerland) 2016 4(1)
• Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome.
  Trepanier Angela M et al. Healthcare (Basel, Switzerland) 2016 4(1)
• Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.
  Evans Chalanda et al. Healthcare (Basel, Switzerland) 2016 4(3)
• BRCA1 and BRCA2 sequence variations detected with next-generation sequencing in patients with premature ovarian insufficiency.
  Y?lmaz Nafiye Karaka?, et al. Journal of the Turkish German Gynecological Association 2016 0 (2) 77-82
• Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
  Staudigl Christine et al. BMC cancer 2016 16436
• The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.
  Hurtado-de-Mendoza Alejandra et al. Journal of genetic counseling 2016 Jul
• Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
  Schenkel Laila C, et al. The Journal of molecular diagnostics : JMD 2016 7
• Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.
  Kang Hyunseok P, et al. PeerJ 2016 0 e2162
• Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm.
  Morris Brian et al. BMC genetics 2016 17(1) 99
• Genetic counseling content: How does it impact health behavior?
  Kelly Kimberly M et al. Journal of behavioral medicine 2015 Oct 38(5) 766-76
• Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation.
  Apostolou Paraskevi, et al. Clinical genetics 2016 6
• Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer.
  Miresmaeili Seyed Mohsen, et al. International journal of reproductive biomedicine (Yazd, Iran) 2016 4 (4) 271-4
• Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.
  Biglia Nicoletta, et al. Ecancermedicalscience 2016 0 639
• Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
  Streff Haley et al. The oncologist 2016 Jun
• Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
  Randall Thomas C et al. Current treatment options in oncology 2016 Aug 17(8) 39

• CDC Information (7)
• CDC-Authored Pub (1)

• Human (22)
• Pathogen (0)

• Human (687)
• Pathogen (0)

• Human (146)
• Pathogen (0)

• Guidelines (8)
• Tier Table (3)
• Synthesis (8)

• Huamn (81)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB